TruAlt Bioenergy
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
TruAlt Bioenergy scheduled one-to-one meetings with institutional investors in Mumbai from 18 to 20 August 2026. The listed participants included Abakkus Mutual Fund, Invesco Mutual Fund, Singularity AMC and Tata Mutual Fund, among others. The meetings were to be based on publicly available information, and no unpublished price-sensitive information was to be shared. They were to be held at the investors’ respective offices and moderated by InCred Research Services. TruAlt generated about ₹1,730 crore of consolidated revenue from operations in FY26 and had 2,000 KLPD of installed ethanol capacity.
Powered by Tijori
TruAlt Bioenergy scheduled one-to-one meetings with institutional investors in Mumbai from 18 to 20 August 2026. The listed participants included Abakkus Mutual Fund, Invesco Mutual Fund, Singularity AMC and Tata Mutual Fund, among others. The meetings were to be based on publicly available information, and no unpublished price-sensitive information was to be shared. They were to be held at the investors’ respective offices and moderated by InCred Research Services. TruAlt generated about ₹1,730 crore of consolidated revenue from operations in FY26 and had 2,000 KLPD of installed ethanol capacity.
Powered by Tijori
TruAlt Bioenergy's promoter-group shareholder Nirani Holdings bought 24,200 shares for ₹1.16 crore at an average price of ₹478.38 on the NSE on 11 August. NHPL's holding rose from 1.63% to 1.65%, reaching 14,19,136 shares. The purchase followed two open-market acquisitions in August that had taken the holding from 1.45% to 1.63% and totalled about ₹7.13 crore. TruAlt reported Q1 FY27 total income of ₹641.41 crore, EBITDA of ₹132.76 crore and profit after tax of ₹59.27 crore.
Powered by Tijori
TruAlt Bioenergy's promoter-group shareholder Nirani Holdings bought 24,200 shares for ₹1.16 crore at an average price of ₹478.38 on the NSE on 11 August. NHPL's holding rose from 1.63% to 1.65%, reaching 14,19,136 shares. The purchase followed two open-market acquisitions in August that had taken the holding from 1.45% to 1.63% and totalled about ₹7.13 crore. TruAlt reported Q1 FY27 total income of ₹641.41 crore, EBITDA of ₹132.76 crore and profit after tax of ₹59.27 crore.
Powered by Tijori
TruAlt Bioenergy’s promoter-group entity Nirani Holdings bought 57,801 shares in the open market for ₹2.76 crore at an average price of ₹478.16. NHPL’s holding rose from 1.56% to 1.63%, or 13,94,936 shares. The purchase followed its acquisition of 91,705 shares for ₹4.37 crore on 7 August, which had taken its stake to 1.56%. TruAlt reported about ₹1,730 crore of consolidated revenue from operations in FY26, while net debt was about ₹1,646 crore.
Powered by Tijori
TruAlt Bioenergy’s promoter-group entity Nirani Holdings bought 57,801 shares in the open market for ₹2.76 crore at an average price of ₹478.16. NHPL’s holding rose from 1.56% to 1.63%, or 13,94,936 shares. The purchase followed its acquisition of 91,705 shares for ₹4.37 crore on 7 August, which had taken its stake to 1.56%. TruAlt reported about ₹1,730 crore of consolidated revenue from operations in FY26, while net debt was about ₹1,646 crore.
Powered by Tijori
TruAlt Bioenergy’s promoter-group company, Nirani Holdings, bought 91,705 equity shares in the open market on August 7, 2026, at an average price of ₹476.14 each. The ₹4.37 crore purchase lifted Nirani Holdings’ holding from 1.45% to 1.56%, or 13,37,135 shares. TruAlt operated ethanol, compressed biogas and other distillery businesses, with installed ethanol capacity of 2,000 KLPD and 65% of that capacity configured for dual-feed production. Net debt stood at approximately ₹1,646 crore in FY26, while June-quarter EBITDA was ₹132.76 crore and profit was ₹59.27 crore.
Powered by Tijori
TruAlt Bioenergy’s promoter-group company, Nirani Holdings, bought 91,705 equity shares in the open market on August 7, 2026, at an average price of ₹476.14 each. The ₹4.37 crore purchase lifted Nirani Holdings’ holding from 1.45% to 1.56%, or 13,37,135 shares. TruAlt operated ethanol, compressed biogas and other distillery businesses, with installed ethanol capacity of 2,000 KLPD and 65% of that capacity configured for dual-feed production. Net debt stood at approximately ₹1,646 crore in FY26, while June-quarter EBITDA was ₹132.76 crore and profit was ₹59.27 crore.
Powered by Tijori
Nirani Holdings Private Limited, a promoter-group shareholder of TruAlt Bioenergy, bought 21,600 equity shares on the NSE at an average price of ₹462.98, spending about ₹1 crore. The purchase was made on 5 August and increased its holding from 1.43% to 1.45%. TruAlt reported consolidated total income of ₹1,813.96 crore for FY26 and operated 2,000 KLPD of installed ethanol capacity. Ethanol accounted for roughly 78% of FY25 revenue, with compressed biogas and other distillery products making up the balance.
Powered by Tijori
Nirani Holdings Private Limited, a promoter-group shareholder of TruAlt Bioenergy, bought 21,600 equity shares on the NSE at an average price of ₹462.98, spending about ₹1 crore. The purchase was made on 5 August and increased its holding from 1.43% to 1.45%. TruAlt reported consolidated total income of ₹1,813.96 crore for FY26 and operated 2,000 KLPD of installed ethanol capacity. Ethanol accounted for roughly 78% of FY25 revenue, with compressed biogas and other distillery products making up the balance.
Powered by Tijori
TruAlt Bioenergy promoter-group entity Nirani Holdings bought 21,600 equity shares through the NSE at an average price of ₹462.98, spending about ₹1 crore. The 5 August purchase lifted Nirani Holdings’ stake from 1.43% to 1.45%, or 12,45,430 shares. TruAlt operates an ethanol-led bioenergy business, with compressed biogas and other distillery products alongside ethanol. Consolidated revenue from operations was about ₹1,730 crore in FY26, while net debt stood at approximately ₹1,646 crore. In the June quarter of FY27, the company reported total income of ₹641.41 crore and net profit of ₹59.27 crore.
Powered by Tijori
TruAlt Bioenergy promoter-group entity Nirani Holdings bought 21,600 equity shares through the NSE at an average price of ₹462.98, spending about ₹1 crore. The 5 August purchase lifted Nirani Holdings’ stake from 1.43% to 1.45%, or 12,45,430 shares. TruAlt operates an ethanol-led bioenergy business, with compressed biogas and other distillery products alongside ethanol. Consolidated revenue from operations was about ₹1,730 crore in FY26, while net debt stood at approximately ₹1,646 crore. In the June quarter of FY27, the company reported total income of ₹641.41 crore and net profit of ₹59.27 crore.
Powered by Tijori
TruAlt Bioenergy's board approved the sale of its Unit 5 undertaking at Badami, Karnataka, to Onkar Agro Sugars & Energy for ₹171 crore by way of a slump sale. The unit contributed no revenue in the year to March 2026 and carries an outstanding term loan of about ₹135 crore from IREDA; its net assets represent 10.53% of the company's net worth. Sale proceeds will be used primarily to repay that debt, with the balance deployed in core operations. The company, an ethanol and compressed biogas producer, reported revenue of ₹62,688 lakh in the June quarter with an EBITDA margin of 23.5%. The definitive agreement is expected to close by 4 November, subject to due diligence and approvals.
Powered by Tijori
TruAlt Bioenergy's board approved the sale of its Unit 5 undertaking at Badami, Karnataka, to Onkar Agro Sugars & Energy for ₹171 crore by way of a slump sale. The unit contributed no revenue in the year to March 2026 and carries an outstanding term loan of about ₹135 crore from IREDA; its net assets represent 10.53% of the company's net worth. Sale proceeds will be used primarily to repay that debt, with the balance deployed in core operations. The company, an ethanol and compressed biogas producer, reported revenue of ₹62,688 lakh in the June quarter with an EBITDA margin of 23.5%. The definitive agreement is expected to close by 4 November, subject to due diligence and approvals.
Powered by Tijori
July 28 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
JUNE-QUARTER CONSOL NET PROFIT 571.5 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 6.27 BILLION RUPEES
Further company coverage: TRUA.NS
(([email protected];;))
July 28 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
JUNE-QUARTER CONSOL NET PROFIT 571.5 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 6.27 BILLION RUPEES
Further company coverage: TRUA.NS
(([email protected];;))
TruAlt Bioenergy has secured ₹150 crore in financial assistance from the Indian government under the PM JI-VAN Yojana for its planned sustainable aviation fuel facility in Bagalkot, Karnataka. The grant, approved by the Centre for High Technology under the Ministry of Petroleum and Natural Gas, is expected to cover 7-10% of the project's capital expenditure. The facility is designed to produce 10 crore litres of SAF annually, supporting India's mandate to blend 1% SAF by 2027 and 5% by 2030. The project positions TruAlt to benefit from global aviation decarbonisation under the CORSIA scheme.
Powered by Tijori
TruAlt Bioenergy has secured ₹150 crore in financial assistance from the Indian government under the PM JI-VAN Yojana for its planned sustainable aviation fuel facility in Bagalkot, Karnataka. The grant, approved by the Centre for High Technology under the Ministry of Petroleum and Natural Gas, is expected to cover 7-10% of the project's capital expenditure. The facility is designed to produce 10 crore litres of SAF annually, supporting India's mandate to blend 1% SAF by 2027 and 5% by 2030. The project positions TruAlt to benefit from global aviation decarbonisation under the CORSIA scheme.
Powered by Tijori
June 18 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
TRUALT BIOENERGY - SECURES 1.50 BILLION RUPEES FINANCIAL ASSISTANCE FOR SUSTAINABLE AVIATION FUEL PROJECT
Source text: ID:nBSE15bxnf
Further company coverage: TRUA.NS
(([email protected];))
June 18 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
TRUALT BIOENERGY - SECURES 1.50 BILLION RUPEES FINANCIAL ASSISTANCE FOR SUSTAINABLE AVIATION FUEL PROJECT
Source text: ID:nBSE15bxnf
Further company coverage: TRUA.NS
(([email protected];))
March 19 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
GAIL INVESTS 130 MILLION RUPEES IN TRUALT BIOENERGY'S SUBSIDIARY LEAFINITI
Source text: ID:nBSE2NLHK4
Further company coverage: TRUA.NS
(([email protected];;))
March 19 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
GAIL INVESTS 130 MILLION RUPEES IN TRUALT BIOENERGY'S SUBSIDIARY LEAFINITI
Source text: ID:nBSE2NLHK4
Further company coverage: TRUA.NS
(([email protected];;))
Feb 6 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
TRUALT BIOENERGY - HIGH COURT ALLOWS WRIT PETITION REGARDING ETHANOL ALLOCATED TO OMCS
Source text: ID:nBSE33FnrL
Further company coverage: TRUA.NS
(([email protected];))
Feb 6 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
TRUALT BIOENERGY - HIGH COURT ALLOWS WRIT PETITION REGARDING ETHANOL ALLOCATED TO OMCS
Source text: ID:nBSE33FnrL
Further company coverage: TRUA.NS
(([email protected];))
Feb 3 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
TRUALT BIOENERGY DEC-QUARTER CONSOL NET PROFIT 693.3 MILLION RUPEES
TRUALT BIOENERGY DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 7.13 BILLION RUPEES
Source text: ID:nBSEcbSJmr
Further company coverage: TRUA.NS
(([email protected];))
Feb 3 (Reuters) - TruAlt Bioenergy Ltd TRUA.NS:
TRUALT BIOENERGY DEC-QUARTER CONSOL NET PROFIT 693.3 MILLION RUPEES
TRUALT BIOENERGY DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 7.13 BILLION RUPEES
Source text: ID:nBSEcbSJmr
Further company coverage: TRUA.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does TruAlt Bioenergy do?
Trualt Bioenergy is one of India’s largest biofuels producers, having strategically positioned its elves as a prominent and diversified player in the biofuels industry in India, primarily in the production of Ethanol. It also produces extra neutral alcohol and sells dry ice and liquid carbon-dioxide, being by-products of its production processes.
Who are the competitors of TruAlt Bioenergy?
TruAlt Bioenergy major competitors are Balrampur Chini Mill, Triveni Engg. & Inds, Dalmia Bharat Sugar, Banna Amman Sugars. Market Cap of TruAlt Bioenergy is ₹3,656 Crs. While the median market cap of its peers are ₹5,563 Crs.
Is TruAlt Bioenergy financially stable compared to its competitors?
TruAlt Bioenergy seems to be less financially stable compared to its competitors. Altman Z score of TruAlt Bioenergy is 2.36 and is ranked 5 out of its 5 competitors.
Does TruAlt Bioenergy pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. TruAlt Bioenergy latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has TruAlt Bioenergy allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory
How strong is TruAlt Bioenergy balance sheet?
Balance sheet of TruAlt Bioenergy is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of TruAlt Bioenergy improving?
The profit is oscillating. The profit of TruAlt Bioenergy is ₹151 Crs for TTM, ₹95.95 Crs for Mar 2026 and ₹147 Crs for Mar 2025.
Is the debt of TruAlt Bioenergy increasing or decreasing?
Yes, The net debt of TruAlt Bioenergy is increasing. Latest net debt of TruAlt Bioenergy is ₹1,466 Crs as of Mar-26. This is greater than Mar-25 when it was ₹1,250 Crs.
Is TruAlt Bioenergy stock expensive?
TruAlt Bioenergy is not expensive. Latest PE of TruAlt Bioenergy is 24.63, while 3 year average PE is 28.69. Also latest EV/EBITDA of TruAlt Bioenergy is 13.68 while 3yr average is 31.22.
Has the share price of TruAlt Bioenergy grown faster than its competition?
There is not enough historical data for the companies share price.
Is the promoter bullish about TruAlt Bioenergy?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in TruAlt Bioenergy is 70.55% and last quarter promoter holding is 70.55%.
Are mutual funds buying/selling TruAlt Bioenergy?
The mutual fund holding of TruAlt Bioenergy is increasing. The current mutual fund holding in TruAlt Bioenergy is 6.76% while previous quarter holding is 6.7%.